Microcirculation · 2020 · 19 citations · 29 references
MedicineClinical SciencesNephrologyDiabetologyRenal PathologyRenal PathophysiologyChronic Kidney DiseaseDiabetic Kidney DiseaseDiabetic NephropathyMicrocirculatory DysfunctionMicrocirculatory PhysiologyMicrovascular Dysfunction AssessmentCapillary FlowFunctional HyperemiaMicrocirculatory DisturbanceMicrocirculatory FlowMicrocirculatory HemodynamicsMicrocirculatory ImpairmentMicrovascular HemodynamicsRenal Microcirculatory Dysfunction
Abstract Objective Endothelial dysfunction has been associated with increased cardiovascular events and overall mortality. Microvascular damage is prevalent both in diabetes mellitus (DM) and chronic kidney disease (CKD). Our aim was to compare microcirculatory function parameters in diabetic and non‐diabetic CKD patients via nailfold video‐capillaroscopy. Methods We included 48 diabetic and 48 non‐diabetic adult CKD patients. All participants underwent nailfold video‐capillaroscopy, during which capillary density was measured at normal conditions (baseline), after a 4‐minute arterial occlusion (postocclusive reactive hyperemia), and at the end of a 2‐minute venous occlusion (congestion phase). Results Diabetic patients presented significantly lower capillary density during reactive hyperemia (36.3 ± 3.8 vs 38.3 ± 4.3 capillaries/mm 2 , P = .022) and at venous congestion (37.8 ± 4.0 vs 39.8 ± 4.2 capillaries/mm 2 , P = .015). When stratified according to CKD stages, only in stage 3b capillary density was significantly lower in diabetic compared to non‐diabetic subjects at baseline, during postocclusive hyperemia (36.8 ± 2.7 vs 40.0 ± 4.3 capillaries/mm 2 , P = .037) and venous congestion (38.3 ± 2.8 vs 41.5 ± 3.5 capillaries/mm 2 , P = .022). Conclusions Capillary density during postocclusive hyperemia and after venous congestion is lower in diabetic compared to non‐diabetic CKD patients, a finding indicative that diabetes is an additional factor contributing to microcirculatory structural and functional impairment in CKD. These differences are more prominent in CKD stage 3b.
29
2013 ESH/ESC Guidelines for the management of arterial hypertension
Giuseppe Mancia, Robert Fagard, Krzysztof Narkiewicz et al. · European Heart Journal · 2013 · 13.7K citations · Full text
2018 ESC/ESH Guidelines for the management of arterial hypertension
Bryan Williams, Giuseppe Mancia, Wilko Spiering et al. · Journal of Hypertension · 2018 · 2.8K citations
Vascular Endothelial Dysfunction and Mortality Risk in Patients With Chronic Heart Failure
Stuart D. Katz, Katarzyna Hryniewicz, Ingrid Hriljac et al. · Circulation · 2005 · 409 citations
Medicine, Cardiology, Physiology +17